Celgene scores at ASH18 with double luspatercept data

Celgene scores at ASH18 with double luspatercept data

Source: 
Pharmaforum
snippet: 

A pair of clinical trial wins for Celgene’s luspatercept at the American Society of Haematology (ASH) meeting have set up a filing for the new drug in mid-2019.